BIONDVAX PHARMACEUTICALS LTD. Jerusalem BioPark, 2 nd Floor Hadassah Ein Kerem Campus Jerusalem, Israel NOTICE OF EXTRAORDINARY MEETING OF SHAREHOLDERS To Be Held on

BIONDVAX PHARMACEUTICALS LTD.

Jerusalem BioPark, 2nd Floor

Hadassah Ein Kerem Campus

NOTICE OF EXTRAORDINARY MEETING OF SHAREHOLDERS

To Be Held on March 31, 2021

An Extraordinary Meeting

of Shareholders of BiondVax Pharmaceuticals Ltd. (the "Company") will be held at the offices of Gross & Co., One

Azrieli Center, Round Tower, Tel Aviv 6701101, Israel on March 31, 2021 at 4:00 p.m. Israel time, or at any adjournments thereof

(the "Extraordinary Meeting") for the following purposes:

The Company is currently

unaware of any other matters that may be raised at the Extraordinary Meeting. Should any other matters be properly raised at the

Extraordinary Meeting, the persons designated as proxies shall vote according to their own judgment on those matters.

Only holders of record

of ordinary shares, no par value (the "Ordinary Shares"), and holders of record of American Depositary Shares ("ADSs"),

evidenced by American Depositary Receipts issued by The Bank of New York Mellon, at the close of business on February 22, 2021

shall be entitled to receive notice of and to vote at the Extraordinary Meeting (the "Record Date").

The board of directors

recommends that you vote FOR each of the proposals, as specified on the form of proxy to be provided.

plan to attend the Extraordinary Meeting, it is important that your Ordinary Shares be represented. Accordingly, you are kindly

requested to complete, date, sign and mail the proxy in the envelope to be provided at your earliest convenience. Execution of

a proxy will not in any way affect a shareholder's right to attend the Extraordinary Meeting and vote in person, and any

person giving a proxy has the right to revoke it at any time before it is exercised.

return their proxies to BNY Mellon by the date set forth on their form of proxy.

either registered in the Company's shareholders' register in Israel or who hold Ordinary Shares through members

of the Tel Aviv Stock Exchange may vote their Ordinary Shares either in person or by proxy delivered to the Company together with

an ownership certificate confirming their ownership of the Company's Shares on the record date, which certificate must be

approved by a recognized financial institution, as required by the Israeli Companies Regulations (Proof of Ownership of Shares

for Voting at General Meeting) of 2000, as amended, and may do so through the attached form

of proxy card, which also serves as their voting card, by completing, dating, signing and mailing the proxy card to the Company's

offices so that it is received by the Company no later than on March 31, 2021 at 12:00 p.m. Israel time.

Shareholders wishing

to express their position on an agenda item for this Extraordinary Meeting may do so by submitting a written statement ("Position

Statement") to the Company's offices by no later than March 21, 2021.

Should no legal quorum

be present one-half hour after the scheduled time, the Extraordinary Meeting will be adjourned to one week from that day, at the

same time and place, i.e. on April 7, 2021, at 4:00 p.m. (Israel Time) at the offices of Gross & Co., One Azrieli Center, Round

Tower, Tel Aviv 6701101, Israel. Should such legal quorum not be present half an hour after the time set for the adjourned meeting,

any number of shareholders present, in person or by proxy, will constitute a legal quorum.

documents mentioned therein, as well as the proposed resolutions on the agenda, will be available to be viewed at the Company's

registered office on Jerusalem BioPark, 2nd Floor, Hadassah Ein Kerem Campus, Jerusalem, Israel, Tel: +972-(8)-930-2529,

Sunday through Thursday between 10:00-15:00, and also will be made available to the public on the Company's website http://www.biondvax.com

and the Commission's website at http://www.sec.gov.